Clinical Trial Update: CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating capsaicin as a chemopreventive agent for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Capsaicin (capsaicin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN